Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy
Zentalis appointed Shannon Campbell to its Board of Directors and Sarah Kelly as Senior Vice President of Commercial Strategy to strengthen commercial leadership. Campbell brings over 30 years of experience, including roles at Merus, Novartis, and Bayer, while Kelly brings extensive background in launch readiness from Amgen and others.
Key figures
- Trial name
- DENALI Phase 2
- Confirmatory trial
- ASPENOVA Phase 3
- Trial readout timeline
- year-end 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.